Healthcare -
Biotechnology - NASDAQ - US
$ 11.2
1.08 %
$ 454 M
Market Cap
-2.24
P/E
KROS - REVENUE
Revenue KROS - Keros Therapeutics, Inc.
151 K
LAST VALUE
-91.33%
2 YEAR CAGR
-56.77%
5 YEAR CAGR
0.00%
10 YEAR CAGR